Part 5: Acute coronary syndromes. Resuscitation 2005; 67: 249-69 - Стандарты ведения пациентов после остановки сердца

Part 5: Acute coronary syndromes. Resuscitation 2005; 67: 249-69.
44. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary
angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J
Med 2003; 349: 733-42.
45. Berger PB, Ellis SG, Holmes DR, Jr., et al. Relationship between delay in
performing direct coronary angioplasty and early clinical outcome in patients
with acute myocardial infarction: results from the global use of strategies to
open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
Circulation 1999; 100: 14-20.
46. A clinical trial comparing primary coronary angioplasty with tissue
plasminogen activator for acute myocardial infarction. The Global Use of
Strategies to Open Occluded Coronary Arteries in Acute Coronary
Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med
1997; 336: 1621-8.
47. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute
myocardial infarction complicated by cardiogenic shock. SHOCK
Investigators. Should We Emergently Revascularize Occluded Coronaries for
Cardiogenic Shock. N Engl J Med 1999; 341: 625-34.
48. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary
angioplasty vs immediate thrombolysis in acute myocardial infarction. Final
results of the randomized national multicentre trial--PRAGUE-2. Eur Heart J
2003; 24: 94-104.
49. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of
patients with early (4 h) presentation
treated by primary coronary angioplasty or thrombolytic therapy for acute
myocardial infarction. Eur Heart J 2002; 23: 550-7.
50. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary
angioplasty versus immediate thrombolysis in acute myocardial infarction: a
meta-analysis. Circulation 2003; 108: 1809-14.
51. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous
thrombolytic therapy for acute myocardial infarction: a quantitative review of
23 randomised trials. Lancet 2003; 361: 13-20.
52. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary
angioplasty and intravenous thrombolytic therapy for acute myocardial
infarction: a quantitative review [published correction appears in JAMA.
1998;279:1876]. JAMA 1997; 278: 2093-8.
53. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated
percutaneous coronary interventions for ST-elevation myocardial infarction:
quantitative review of randomised trials. Lancet 2006; 367: 579-88.
54. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in
survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40: 2110-6.
55. Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S, et al. Reversible
myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation
2005; 66: 175-81.
56. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after
resuscitation from cardiac arrest: an example of global myocardial stunning. J
Am Coll Cardiol 1996; 28: 232-40.
57. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary
resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation
2002; 106: 562-8.
58. Mullner M, Sterz F, Binder M, et al. Arterial blood pressure after human
cardiac arrest and neurological recovery. Stroke 1996; 27: 59-62.
59. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clinical
practice: effective implementation of therapeutic hypothermia to improve
patient outcome after cardiac arrest. Crit Care Med 2006; 34: 1865-73.
60. Myerburg RJ, Briese FW, Conde C, et al. Long-term antiarrhythmic therapy in
survivors of prehospital cardiac arrest. Initial 18 months' experience. JAMA
1977; 238: 2621-4.
61. Somberg JC, Laux B, Wynn J, Keefe D, Miura DS. Lorcainide therapy in a
cardiac arrest population. Am Heart J 1986; 111: 648-53.
62. Moosvi AR, Goldstein S, VanderBrug Medendorp S, et al. Effect of empiric
antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims
with coronary artery disease. Am J Cardiol 1990; 65: 1192-7.
63. Haverkamp W, Martinez-Rubio A, Hief C, et al. Efficacy and safety of d,lsotalol
in patients with ventricular tachycardia and in survivors of cardiac
arrest. J Am Coll Cardiol 1997; 30: 487-95.
64. Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. An
antiarrhythmic drug experience in 941 patients resuscitated from an initial
cardiac arrest between 1970 and 1985. Am J Cardiol 1991; 68: 1025-31.
65. Peter T, Hamer A, Weiss D, Mandel WJ. Prognosis after sudden cardiac
death without associated myocardial infarction: one year follow-up of empiric
therapy with amiodarone. Am Heart J 1984; 107: 209-13.
66. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the
CASCADE Study). The CASCADE Investigators. Am J Cardiol 1993; 72: 280-
67. Wever EFD, Hauer RNW, Van Capelle FJL, et al. Randomized study of
implantable defibrillator as first-choice therapy versus conventional strategy in
postinfarct sudden death survivors. Circulation 1995; 91: 2195-203.
68. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in
patients resuscitated from near-fatal ventricular arrhythmias. The
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl
J Med 1997; 337: 1576-83.
69. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator
study (CIDS): A randomized trial of the implantable cardioverter defibrillator
against amiodarone. Circulation 2000; 101: 1297-302.
70. Connolly SJ, Hallstrom AP, Cappato R, et al. Metal-analysis of the
implantable cardioverter defibrillator secondary prevention trials. Eur Heart J
2000; 21: 2071-8.
71. Hennersdorf MG, Niebch V, Vester EG, et al. Long-term follow-up of sudden
cardiac arrest survivors and electrophysiologically guided antiarrhythmic
therapy. Cardiology 2003; 99: 190-7.
72. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers,
amiodarone plus beta-blockers, or sotalol for prevention of shocks from
implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Jama 2006; 295: 165-71.
73. Martin GB, Nowak RM, Cisek JE, Carden DL, Tomlanovich MC.
Hyperkalemia during human cardiopulmonary resuscitation: incidence and
ramifications. J Emerg Med 1989; 7: 109-13.
74. Hekimian G, Baugnon T, Thuong M, et al. Cortisol levels and adrenal reserve
after successful cardiac arrest resuscitation. Shock 2004; 22: 116-9.
75. Schultz CH, Rivers EP, Feldkamp CS, et al. A characterization of
hypothalamic-pituitary-adrenal axis function during and after human cardiac
arrest. Crit Care Med 1993; 21: 1339-47.
76. Pene F, Hyvernat H, Mallet V, et al. Prognostic value of relative adrenal
insufficiency after out-of-hospital cardiac arrest. Intensive Care Med 2005; 31:
77. Kim JJ, Lim YS, Shin JH, et al. Relative adrenal insufficiency after cardiac
arrest: impact on postresuscitation disease outcome. Am J Emerg Med 2006;
24: 684-8.
78. Miller JB, Donnino MW, Rogan M, Goyal N. Relative adrenal insufficiency in
post-cardiac arrest shock is under-recognized. Resuscitation 2007.
79. Tsai MS, Huang CH, Chang WT, et al. The effect of hydrocortisone on the
outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg
Med 2007; 25: 318-25.
80. Adrie C, Monchi M, Laurent I, et al. Coagulopathy after successful
cardiopulmonary resuscitation following cardiac arrest: implication of the
protein C anticoagulant pathway. J Am Coll Cardiol 2005; 46: 21-8.
81. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after outof-
hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005; 46:
82. Neumar RW. Molecular mechanisms of ischemic neuronal injury. Ann Emerg
Med 2000; 36: 483-506.
83. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-
84. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia.
Stroke 2007; 38: 674-6.
85. Ames A, 3rd, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral
ischemia. II. The no-reflow phenomenon. Am J Pathol 1968; 52: 437-53.
86. Wolfson SK, Jr., Safar P, Reich H, et al. Dynamic heterogeneity of cerebral
hypoperfusion after prolonged cardiac arrest in dogs measured by the stable
xenon/CT technique: a preliminary study. Resuscitation 1992; 23: 1-20.
87. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients
resuscitated after cardiac arrest. Acta Anaesthesiol Scand 1996; 40: 1149-53.
88. Angelos MG, Ward KR, Hobson J, Beckley PD. Organ blood flow following
cardiac arrest in a swine low-flow cardiopulmonary bypass model.
Resuscitation 1994; 27: 245-54.
89. Buunk G, van der Hoeven JG, Meinders AE. Cerebral blood flow after cardiac
arrest. Neth J Med 2000; 57: 106-12.
90. Sakabe T, Tateishi A, Miyauchi Y, et al. Intracranial pressure following
cardiopulmonary resuscitation. Intensive Care Med 1987; 13: 256-9.
91. Morimoto Y, Kemmotsu O, Kitami K, Matsubara I, Tedo I. Acute brain swelling
after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med
1993; 21: 104-10.
92. Torbey MT, Selim M, Knorr J, Bigelow C, Recht L. Quantitative analysis of the
loss of distinction between gray and white matter in comatose patients after
cardiac arrest. Stroke 2000; 31: 2163-7.
93. Iida K, Satoh H, Arita K, et al. Delayed hyperemia causing intracranial
hypertension after cardiopulmonary resuscitation. Crit Care Med 1997; 25:
94. Rello J, Diaz E, Roque M, Valles J. Risk factors for developing pneumonia
within 48 hours of intubation. Am J Respir Crit Care Med 1999; 159: 1742-6.
95. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug
disposition, metabolism, and response: A focus of hypothermia-mediated
alterations on the cytochrome P450 enzyme system. Crit Care Med 2007; 35:
96. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome
within the first 3 days of postanoxic coma. Neurology 2006; 66: 62-8.
97. Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary
resuscitation: relation to seizures and myoclonus. Neurology 1988; 38: 401-5.
98. Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxicischemic
coma. JAMA 1985; 253: 1420-6.
99. Snyder BD, Hauser WA, Loewenson RB, et al. Neurologic prognosis after
cardiopulmonary arrest, III: seizure activity. Neurology 1980; 30: 1292-7.
100. Ingvar M. Cerebral blood flow and metabolic rate during seizures.
Relationship to epileptic brain damage. Ann N Y Acad Sci 1986; 462: 194-
101. Caviness JN, Brown P. Myoclonus: current concepts and recent advances.
Lancet Neurol 2004; 3: 598-607.
102. Wijdicks EF. Propofol in myoclonus status epilepticus in comatose patients
following cardiac resuscitation. J Neurol Neurosurg Psychiatry 2002; 73: 94-5.
103. Rundgren M, Rosen I, Friberg H. Amplitude-integrated EEG (aEEG) predicts
outcome after cardiac arrest and induced hypothermia. Intensive Care Med
2006; 32: 836-42.
104. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation.
Intensive Care Med 1991; 17: 419-20.
105. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an
ominous sign after cardiac arrest? Resuscitation 2001; 49: 273-7.
106. Hickey RW, Kochanek PM, Ferimer H, et al. Induced hyperthermia
exacerbates neurologic neuronal histologic damage after asphyxial cardiac
arrest in rats. Crit Care Med 2003; 31: 531-5.
107. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is
associated with an unfavorable neurologic outcome. Arch Intern Med 2001;
161: 2007-12.
108. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage
in the rat brain by late treatment with the antipyretic drug dipyrone or cooling
following cerebral ischemia. Acta Neuropathol (Berl) 1996; 92: 447-53.
109. Coimbra C, Drake M, Boris-Moller F, Wieloch T. Long-lasting neuroprotective
effect of postischemic hypothermia and treatment with an antiinflammatory/
antipyretic drug: evidence for chronic encephalopathic
processes following ischemia. Stroke 1996; 27: 1578-85.
110. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia
to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;
346: 549-56.
111. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of
out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;
346: 557-63.
112. Holzer M, Bernard SA, Hachimi-Idrissi S, et al. Hypothermia for
neuroprotection after cardiac arrest: systematic review and individual patient
data meta-analysis. Crit Care Med 2005; 33: 414-8.
113. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia in
comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 1997;
30: 146-53.
114. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid
implementation of therapeutic hypothermia in comatose out-of-hospital
cardiac arrest survivors. Acta Anaesthesiol Scand 2006; 50: 1277-83.
115. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac
arrest. Crit Care Med 2007; 35: 1041-7.
116. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular
cooling after cardiac arrest: cohort study and Bayesian approach. Stroke
2006; 37: 1792-7.
117. Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L. Mild
hypothermia induced by a helmet device: a clinical feasibility study.
Resuscitation 2001; 51: 275-81.
118. Kim F, Olsufka M, Longstreth WT, Jr., et al. Pilot randomized clinical trial of
prehospital induction of mild hypothermia in out-of-hospital cardiac arrest
patients with a rapid infusion of 4 degrees C normal saline. Circulation 2007;
115: 3064-70.
119. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large
© 8712.ru
Образовательные документы для студентов.